These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


376 related items for PubMed ID: 15948867

  • 41. Nephron number determines susceptibility to renal mass reduction-induced CKD in Lewis and Fisher 344 rats: implications for development of experimentally induced chronic allograft nephropathy.
    Szabo AJ, Muller V, Chen GF, Samsell LJ, Erdely A, Baylis C.
    Nephrol Dial Transplant; 2008 Aug; 23(8):2492-5. PubMed ID: 18332065
    [Abstract] [Full Text] [Related]

  • 42. Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection.
    Tullius SG, Heemann U, Hancock WW, Azuma H, Tilney NL.
    Ann Surg; 1994 Oct; 220(4):425-32; discussion 432-5. PubMed ID: 7944655
    [Abstract] [Full Text] [Related]

  • 43. Captopril preserves function and ultrastructure in experimental radiation nephropathy.
    Cohen EP, Molteni A, Hill P, Fish BL, Ward WF, Moulder JE, Carone FA.
    Lab Invest; 1996 Sep; 75(3):349-60. PubMed ID: 8804358
    [Abstract] [Full Text] [Related]

  • 44. Chronic allograft nephropathy.
    Najafian B, Kasiske BL.
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
    [Abstract] [Full Text] [Related]

  • 45. Apoptosis and treatment of chronic allograft nephropathy with everolimus.
    Lutz J, Zou H, Liu S, Antus B, Heemann U.
    Transplantation; 2003 Aug 15; 76(3):508-15. PubMed ID: 12923436
    [Abstract] [Full Text] [Related]

  • 46. Renoprotective effects of the AGE-inhibitor pyridoxamine in experimental chronic allograft nephropathy in rats.
    Waanders F, van den Berg E, Nagai R, van Veen I, Navis G, van Goor H.
    Nephrol Dial Transplant; 2008 Feb 15; 23(2):518-24. PubMed ID: 17905804
    [Abstract] [Full Text] [Related]

  • 47. Clinical significance of allograft glomerulopathy.
    Habib R, Broyer M.
    Kidney Int Suppl; 1993 Oct 15; 43():S95-8. PubMed ID: 8246379
    [Abstract] [Full Text] [Related]

  • 48. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy.
    Ishii Y, Sawada T, Kubota K, Fuchinoue S, Teraoka S, Shimizu A.
    Kidney Int; 2005 Jan 15; 67(1):321-32. PubMed ID: 15610258
    [Abstract] [Full Text] [Related]

  • 49. Treatment of chronic renal allograft rejection in rats with a low-molecular-weight heparin (reviparin).
    Braun C, Schultz M, Fang L, Schaub M, Back WE, Herr D, Laux V, Rohmeiss P, Schnuelle P, van der Woude FJ.
    Transplantation; 2001 Jul 27; 72(2):209-15. PubMed ID: 11477340
    [Abstract] [Full Text] [Related]

  • 50. Kidney pathology in liver allograft recipients after long-term treatment with cyclosporin A.
    Dische FE, Neuberger J, Keating J, Parsons V, Calne RY, Williams R.
    Lab Invest; 1988 Apr 27; 58(4):395-402. PubMed ID: 3282124
    [Abstract] [Full Text] [Related]

  • 51. Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats.
    Le Berre L, Godfrin Y, Günther E, Buzelin F, Perretto S, Smit H, Kerjaschki D, Usal C, Cuturi C, Soulillou JP, Dantal J.
    J Clin Invest; 2002 Feb 27; 109(4):491-8. PubMed ID: 11854321
    [Abstract] [Full Text] [Related]

  • 52. Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury.
    Cassis P, Gallon L, Benigni A, Mister M, Pezzotta A, Solini S, Gagliardini E, Cugini D, Abbate M, Aiello S, Rocchetta F, Scudeletti P, Perico N, Noris M, Remuzzi G.
    Kidney Int; 2012 May 27; 81(9):903-18. PubMed ID: 22318420
    [Abstract] [Full Text] [Related]

  • 53. Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney.
    Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL.
    Transplantation; 1997 Jul 27; 64(2):190-7. PubMed ID: 9256172
    [Abstract] [Full Text] [Related]

  • 54. Antigen-independent events mimic characteristic changes of chronic allograft rejection.
    Tullius SG, Heemann UW, Azuma H, Hancock WW, Pradham P, Tilney NL.
    Transplant Proc; 1995 Feb 27; 27(1):561-3. PubMed ID: 7879099
    [No Abstract] [Full Text] [Related]

  • 55. The impact of immune-activating processes following transplantation on chronic allograft nephropathy.
    Heidenhain C, Reutzel-Selke A, Bachmann U, Jonas S, Pascher A, Ulrich F, Pratschke J, Neuhaus P, Volk HD, Tullius SG.
    Kidney Int; 2003 Sep 27; 64(3):1125-33. PubMed ID: 12911566
    [Abstract] [Full Text] [Related]

  • 56. Glomerular pathology of allograft kidneys in Hong Kong.
    Chan KW, Chan GS, Tang S.
    Transplant Proc; 2005 Dec 27; 37(10):4293-6. PubMed ID: 16387100
    [Abstract] [Full Text] [Related]

  • 57. Impact of HLA antibodies on transplant glomerulopathy.
    Palomar R, López-Hoyos M, Pastor JM, Fernández-Fresnedo G, Rodrigo E, Ruiz JC, Cotorruelo JG, Valero R, Castañeda O, San Segundo D, Arias M.
    Transplant Proc; 2005 Nov 27; 37(9):3830-2. PubMed ID: 16386554
    [Abstract] [Full Text] [Related]

  • 58. Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection.
    Kiss E, Adams J, Gröne HJ, Wagner J.
    Transplantation; 2003 Aug 15; 76(3):480-9. PubMed ID: 12923432
    [Abstract] [Full Text] [Related]

  • 59. Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats.
    Waanders F, Rienstra H, Boer MW, Zandvoort A, Rozing J, Navis G, van Goor H, Hillebrands JL.
    Am J Physiol Renal Physiol; 2009 May 15; 296(5):F1072-9. PubMed ID: 19244402
    [Abstract] [Full Text] [Related]

  • 60. Influence of hypersulfated and low molecular weight heparins on ischemia/reperfusion: injury and allograft rejection in rat kidneys.
    Gottmann U, Mueller-Falcke A, Schnuelle P, Birck R, Nickeleit V, van der Woude FJ, Yard BA, Braun C.
    Transpl Int; 2007 Jun 15; 20(6):542-9. PubMed ID: 17355246
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.